An enhanced ability for transforming adriamycin into a noncytotoxic form in a multidrug-resistant cell line (LZ-8)

This publication has 20 references indexed in Scilit:

• Characterization of adriamycin-resistant and radiation-sensitive Chinese hamster cell lines
  Biochemical Pharmacology, 1992
• Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity
  Pharmacology & Therapeutics, 1990
• Multidrug Resistance
  Published by Elsevier ,1989
• Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans.
  Journal of Clinical Oncology, 1988
• Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays
  Cancer Chemotherapy and Pharmacology, 1986
• Interactions of anticancer quinone drugs, aclacinomycin A, adriamycin, carbazilquinone, and mitomycin C, with NADPH-cytochrome P-450 reductase, xanthine oxidase and oxygen.
  Journal of Pharmacobio-Dynamics, 1986
• 5 Recent Studies on Doxorubicin and its Analogues
  Published by Elsevier ,1985
• Kinetics of anthracycline antibiotic free radical formation and reductive glycosidase activity
  Archives of Biochemistry and Biophysics, 1983
• Endocytosis and the recycling of plasma membrane.
  The Journal of cell biology, 1983
• Daunorubicin and adriamycin metabolism in the golden Syrian hamster
  Biochemical Medicine, 1973